AlphaYou
Overview
Smart money at a glance
Filings to Sep 30, 2026Net selling: insiders sold $4.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: net selling of $2K to $30K in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$4.4M netNet selling
- CongressSTOCK Act, last 180 days
- -$2K to -$30K netNet selling
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 8 added, 2 cutMore adding
Key stats
Fundamentals Sep 30- Open
- $306.20
- 52-wk high
- $375.33
- High
- $307.94
- 52-wk low
- $243.78
- Low
- $302.84
- Prev close
- $306.92
- Mkt cap
- $58.70B
- P/E
- 22.6x
- Volume
- 1.52M
- Fwd P/E
- 15.7x
- Beta
- 0.57
- Div yield
- 0.77%
- P/S
- 0.2x
- P/B
- 19.5x
- Profit margin
- +0.8%
- Op margin
- +1.4%
- ROE
- +96.9%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about COR filings
Are insiders buying or selling Cencora Inc. (COR) stock?
Net selling: insiders sold $4.4M and bought $0 of COR stock on the open market in the 90 days to Sep 30, 2026, according to SEC Form 4 filings. $321K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Campbell, Elizabeth S (Executive Vice President), who sold $3.7M. The latest filing was on Sep 17, 2026.
Which members of Congress have traded COR recently?
Rep. Jared Moskowitz (D) sold $1K to $15K on May 6, 2026, disclosed 44 days later. Rep. Jared Moskowitz (D) sold $1K to $15K on May 6, 2026, disclosed 44 days later. In total, 1 member disclosed 2 COR trades with trade dates in the last 180 days, filed a median 44 days after trading.
How current is this COR smart-money data?
This summary uses filings available on Sep 30, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders are trading both ways.
What funds are doing
Buys/Adds (3)
- BA
Balyasny
$170.9M
added
- MI
Millennium
$151.2M
added
- SQ
Squarepoint
$143.2M
added
What insiders are doing
What Congress is doing
Buys (1)
How top traders are positioned
No tracked top-trader positions in COR right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in 2.5% above what analysts expected.
Earnings per share
$4.37 expected
Revenue
$84.15B expected
GAAP EPS was $3.94 and adjusted EPS was $4.48. The adjusted figure is comparable to consensus.
Reports Nov 4, 2026, in 35 days
Estimates as of Sep 30, 2026
EPS expected
$4.50 to $4.62
Revenue expected
10 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $83.73B | $85.93B | $78.36B | $84.75B |
| Cost of what it sold | $81.13B | $83.12B | $75.03B | $81.15B |
| Gross profit | $2.60B | $2.81B | $3.32B | $3.61B |
| What it spent | ||||
| Sales and admin | $1.75B | $1.80B | $1.98B | $2.13B |
| Other operating costs | — | — | — | $354.6M |
| Total operating expenses | $1.75B | $1.80B | $1.98B | $2.49B |
| What was left | ||||
| Operating profit | $854.6M | $1.02B | $1.34B | $1.12B |
| Interest on debt | $109.4M | $93.4M | $154.3M | $140.7M |
| Profit before tax | -$187.0M | $708.6M | $2.09B | $996.4M |
| Tax | $146.0M | $142.5M | $459.0M | $219.7M |
| Net profit | -$339.7M | $559.6M | $1.64B | $763.5M |
| EBITDA | $183.3M | $1.04B | $2.50B | $1.41B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Cencora Inc Lobbyists, 2014
NeutralSep 27Cencora Elects Ryder Systems' Robert Sanchez to Board
NeutralSep 26ABC5156681 Bond Profile: Coupon and Redemption
NeutralSep 26AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
NeutralSep 25AbbVie vs. Pfizer: Which Healthcare Stock Makes Your Portfolio Healthier in 2026?
NeutralSep 25Form 8K Cencora Inc For: 25 September By Investing.com
NeutralSep 25Cencora Elects Former Ryder CEO Robert Sanchez to Board
BullishSep 25Cencora, Inc. Announces Appointment of Robert E. Sanchez as Independent Director, Effective October 1, 2026
Leans bullishSep 25
Macro
33 macro signals shaping COR right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results